OLD: Cafepharma Detail Piece Daily Pharma Headlines Archive for November, 2017

IMPORTANT: On Sunday, April 22, we send out an email with some important changes to our newsletter service. Please make sure you read this email, or the details on our our newsletter page, as our newsletter service changes will be taking effect on Monday, May 7, 2018.  On that date, your current newsletter subscription will end if you have not subscribed under our new plan. 

Click a link below to view the mailing archive as if it had been sent to you.

2017-11-30 12:15In Search Of Novelty: 2017's New FDA Drug Approvals and more...
2017-11-30 00:15Regeneron and Decibel aren’t just collaborating: They want to create a whole new partnering model and more...
2017-11-29 12:15One big Novartis takeaway from Entresto's slow start? Heart failure doesn't work like oncology and more...
2017-11-29 00:15Which trends will impact pharma marketers in 2018? InVentiv has a few ideas and more...
2017-11-28 12:15FDA Boss Aims To Close EpiPen Loophole and more...
2017-11-28 00:15How much is an FDA shortcut worth to drug developers hustling to an OK? Holding steady at $125M, cash and more...
2017-11-27 12:15Roiled by financial turmoil, Teva’s CEO boots R&D chief, top execs in C-suite overhaul and more...
2017-11-26 00:15J&J & Glaxo's Jucala Approval Puts Spotlight on HIV Space and more...
2017-11-24 12:15Teva R&D chief out as new CEO picks up the ax and aims at deep cuts to rescue a faltering biopharma — report and more...
2017-11-22 12:15Takeda spins off cancer assets to incubated startup and more...
2017-11-22 00:15With billions riding on their success, GSK bags quick OK for its two-drug HIV combo Juluca and more...
2017-11-21 12:15Allergan could sell women's health for $6B, if it would only agree to split: analyst and more...
2017-11-21 00:15FDA adds ‘breakthrough’ status for Alnylam as patisiran starts its victory lap at the agency and more...
2017-11-20 12:15GlaxoSmithKline's Nucala, buoyed by its medical organization, ready to 'fiercely compete' with AstraZeneca and more...
2017-11-19 12:15U.S. biotechs can’t shake October blues as investors await next moves and more...
2017-11-19 00:15[video]Is Loxo Oncology's Deal With Bayer Bad News? and more...
2017-11-18 12:15Nevada refusing Pfizer demand for return of execution drugs and more...
2017-11-17 12:15Cancer Space Update: Label Expansion for Three Major Drugs and more...
2017-11-17 00:15Drug firm founder pleads not guilty to opioid bribe scheme and more...
2017-11-16 12:15How can new launches mimic Keytruda, Harvoni, and Opdivo? A new report has some ideas and more...
2017-11-16 00:15Alkermes touts equal efficacy of monthly Vivitrol against daily Suboxone and more...
2017-11-15 12:15Relax, pharma. Amazon's eyeing medical and device sales before drugs: report and more...
2017-11-15 00:15Hospitals file lawsuit to block 340B drug payment cut and more...
2017-11-14 12:15FDA eyes even more pricing competition with another round of generics moves and more...
2017-11-14 00:15Forget BMS. Pfizer should chase a Biogen buy, analyst suggests and more...
2017-11-13 12:15Trump nominates former pharma exec Azar to head HHS and more...
2017-11-13 00:15Last week in pharma.bio.device.lab November 5-11 2017
2017-11-12 12:15An explosion of PD-1/L1 checkpoint studies is crowding the industry pipeline — and that’s a problem and more...
2017-11-11 12:15After months of searching, Immunomedics lines up Celgene vet Pehl as its new CEO and more...
2017-11-11 00:15Juno analysis of shuttered study offers clues for CAR-T and more...
2017-11-10 12:15Bristol-Myers offers a positive snapshot on early data for an IDO1 rival to Incyte and more...
2017-11-10 00:15AstraZeneca Stock Gains as Crestor Sales Decline Slows and more...
2017-11-09 12:15[forum discussion]RIP Novo and more...
2017-11-09 00:15Amgen Challenge of FDA Decision on Pediatric Exclusivity Could Have Wider Implications and more...
2017-11-08 12:15Limits on pharma payments to doctors back on policy menu and more...
2017-11-08 00:15Allergan executives named in investor suit over alleged generics price fixing and more...
2017-11-07 12:15Drugstore pain pills as effective as opioids in ER patients and more...
2017-11-07 00:15Roche job cuts mount to 365 as drugmaker rethinks packaging and more...
2017-11-06 12:15Trump readies executive order to unravel Obamacare's individual mandate and more...
2017-11-05 12:15Allergan CEO Saunders claims 'tenacity' led company into tribal licensing deal and more...
2017-11-05 00:15Amgen and Genentech are the latest drug makers to lay off workers and more...
2017-11-04 12:15Mallinckrodt continues pipeline revamp with Ocera buy and more...
2017-11-03 12:15GSK and Gilead go head to head as HIV drugs enter new phase and more...
2017-11-03 00:15Most New Drug Patents Are for Old Remedies, Research Shows and more...
2017-11-02 12:15EpiPen Failures Cited in Seven Deaths This Year, FDA Files Show and more...
2017-11-02 00:15Verastem moves closer to US filing for blood cancer drug and more...
2017-11-01 12:15Bristol-Myers Squibb could double patient numbers for Opdivo in kidney cancer and more...
2017-11-01 00:15AstraZeneca wins US approval for lymphoma drug and more...

 

<< Archive IndexSubscribe >>

Contact Us

Past Issues

Unsubscribe